King Pharmaceuticals (KG) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

King Pharmaceuticals (KG)

0.00

-0.00 (0.00%)

0 watching

BUY

A potential takeover play. Has been a bit undermanaged and is very cheap.

BUY

Technical support is $12.75. A lot of upside potential. Fair market value is $35/40. However, earnings forecast trend is in a decline.

PAST TOP PICK

(A top pick Aug 12/03. Up 3%.) Still likes. An outstanding value for investors to focus on.

TOP PICK

Has great value. US Healthcare looks very inexpensive.

TOP PICK

Will be volatile. An OK company at a bargain price. Good risk/reward.

WEAK BUY

Generic drug makers have been on quite a role.A good group to have exposure to.This company has FCC and business model problems.Risky.

TOP PICK

(Was a top pick on July 14, 2003.Up 15%.)Still likes.Good earnings. Came out with a relatively good performance report.Got hit by a sudden move of defense money moving into cyclical areas.Got too cheap.

TOP PICK

Systems indicate a top pick. Cheap and has earnings.

DON'T BUY

Fundamentally should be good, but the stock languishes.

BUY

Cheap/ Good growth prospects. Only own a small portion in your portfolio.

Showing 1 to 10 of 10 entries

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

King Pharmaceuticals (KG) Frequently Asked Questions

What is King Pharmaceuticals stock symbol?

King Pharmaceuticals is a OTC stock, trading under the symbol KG (previously KG-N on Stockchase) on the undefined (undefined). It is usually referred to as or KG

Is King Pharmaceuticals a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on KG (previously KG-N on Stockchase) on Stockchase. Read the latest expert commentary for King Pharmaceuticals.

Is King Pharmaceuticals a good investment or a top pick?

King Pharmaceuticals was recommended as a Top Pick by Robert Floyd on 2002-08-16. Read the latest stock experts ratings for King Pharmaceuticals.

Why is King Pharmaceuticals stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for King Pharmaceuticals.

Is King Pharmaceuticals worth watching?

King Pharmaceuticals is covered by Stockchase experts and is worth watching.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

King Pharmaceuticals (KG)